IL22 and polycystic ovary syndrome: Flow cytometry shows a reduction of ILC3 (CD45+IL-22+RORγt+) in both intestinal and blood samples in PCOS individuals and PCOS-like animal models; furthermore, it also exhibits a therapeutic role in PCOS [57].